Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Zimring

Showing results (11-20 of 216) with videos related to

Pageof 22
Sort By:
Current Opinion in Immunology|August 23, 2025
From metabolomics to transfusion-associated immunomodulationAngelo D'Alessandro, James C Zimring
Immunologic Research|June 8, 2004
Identification and characterization of CD8+ suppressor T cellsJames C Zimring, Judith A Kapp
Transplantation|January 20, 2006
Rapamycin prolongs susceptibility of responding T cells to tolerance induction by CD8+ veto cellsKimberly M Anderson, James C Zimring
Hematology. American Society of Hematology. Education Program|December 4, 2016
Cellular immune responses in red blood cell alloimmunizationJames C Zimring, Krystalyn E Hudson
Transfusion Medicine Reviews|October 16, 2022
Transfusion Medicine in the 21st Century: Beyond Rebalancing the HumorsKrystalyn E Hudson, James C Zimring
Transfusion Medicine Reviews|October 5, 2013
Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigensSeema R Patel, James C Zimring
Vox Sanguinis|May 10, 2008
Cross-linking induces non-haemolytic antigen-loss from transfused red blood cells: a potential role for rheumatoid factorC M Cadwell, J C Zimring
Annual Review of Pathology|January 27, 2015
Pathobiology of transfusion reactionsJames C Zimring, Steven L Spitalnik
Blood|June 9, 2012
Keeping the Kell away from immunityJames C Zimring, Jill M Johnsen
Blood Transfusion = Trasfusione Del Sangue|March 7, 2017
Large retrospective effects, clear differences in animals, and multiple negative randomised controlled trials: this is exactly how it is supposed to workJames C Zimring, Steven L Spitalnik
Pageof 22

Showing results (11-20 of 216) with videos related to

Sort By:
Pageof 22
Current Opinion in Immunology|August 23, 2025
From metabolomics to transfusion-associated immunomodulationAngelo D'Alessandro, James C Zimring
Immunologic Research|June 8, 2004
Identification and characterization of CD8+ suppressor T cellsJames C Zimring, Judith A Kapp
Transplantation|January 20, 2006
Rapamycin prolongs susceptibility of responding T cells to tolerance induction by CD8+ veto cellsKimberly M Anderson, James C Zimring
Hematology. American Society of Hematology. Education Program|December 4, 2016
Cellular immune responses in red blood cell alloimmunizationJames C Zimring, Krystalyn E Hudson
Transfusion Medicine Reviews|October 16, 2022
Transfusion Medicine in the 21st Century: Beyond Rebalancing the HumorsKrystalyn E Hudson, James C Zimring
Transfusion Medicine Reviews|October 5, 2013
Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigensSeema R Patel, James C Zimring
Vox Sanguinis|May 10, 2008
Cross-linking induces non-haemolytic antigen-loss from transfused red blood cells: a potential role for rheumatoid factorC M Cadwell, J C Zimring
Annual Review of Pathology|January 27, 2015
Pathobiology of transfusion reactionsJames C Zimring, Steven L Spitalnik
Blood|June 9, 2012
Keeping the Kell away from immunityJames C Zimring, Jill M Johnsen
Blood Transfusion = Trasfusione Del Sangue|March 7, 2017
Large retrospective effects, clear differences in animals, and multiple negative randomised controlled trials: this is exactly how it is supposed to workJames C Zimring, Steven L Spitalnik
Pageof 22